Mutational spectrum in the Ca2+-activated cation channel gene TRPM4 in patients with cardiac conductance disturbances

Birgit Stallmeyer(Institut für Forensische Genetik), Eric Schulze‐Bahr(University of Münster), Isabelle Denjoy(Assistance Publique – Hôpitaux de Paris), Jean‐Louis Hébert(Sorbonne Université), Svetlana Maugenre(Inserm), Ellen Schulze-Bahr(University Hospital Münster), Sven Zumhagen(Institut für Forensische Genetik), Pascale Guicheney(Sorbonne Université), Xavier Ferrer(Centre Hospitalier Universitaire de Bordeaux), Uwe Kirchhefer(University Hospital Münster), Guillaume Duthoit(Sorbonne Université), Wilhelm Schmitz(University of Münster)
Human Mutation
September 1, 2011
10.1002/humu.21599
Cited by 167

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Allergy|2014|1.2k
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
|Allergy|2004|1.1k
The effect of aortic valve replacement on survival.
|Circulation|1982|587
Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma
|Clinical & Experimental Allergy|2004|520